Cargando…
Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors
Autores principales: | Tennstedt, Pierre, Oh-Hohenhorst, Su Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218455/ https://www.ncbi.nlm.nih.gov/pubmed/37240158 http://dx.doi.org/10.3390/ijms24108812 |
Ejemplares similares
-
Immunotherapy for Solid Tumors
por: de Saint Basile, Hortense, et al.
Publicado: (2023) -
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
por: Tang, Lu, et al.
Publicado: (2023) -
Assessing the Future of Solid Tumor Immunotherapy
por: Guha, Prajna, et al.
Publicado: (2022) -
Challenges and Future Trends of Hepatocellular Carcinoma Immunotherapy
por: Rizzo, Alessandro, et al.
Publicado: (2022) -
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy
por: Oh, Su Jung, et al.
Publicado: (2017)